vs
Side-by-side financial comparison of OLIN Corp (OLN) and UGI CORP (UGI). Click either name above to swap in a different company.
UGI CORP is the larger business by last-quarter revenue ($2.1B vs $1.7B, roughly 1.2× OLIN Corp). UGI CORP runs the higher net margin — 14.4% vs -8.6%, a 23.0% gap on every dollar of revenue. On growth, UGI CORP posted the faster year-over-year revenue change (3.9% vs -0.4%). Over the past eight quarters, OLIN Corp's revenue compounded faster (0.9% CAGR vs -7.5%).
Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Accidents at Olin chemical plants have exposed employees and nearby residents to health hazards.
UGI Corporation is a natural gas and electric power distribution company headquartered in King of Prussia, Pennsylvania, with extensive operations in the United States and Europe.
OLN vs UGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $2.1B |
| Net Profit | $-143.2M | $297.0M |
| Gross Margin | 1.9% | — |
| Operating Margin | -9.4% | 22.0% |
| Net Margin | -8.6% | 14.4% |
| Revenue YoY | -0.4% | 3.9% |
| Net Profit YoY | -1517.8% | -20.8% |
| EPS (diluted) | $-1.25 | $1.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.7B | $2.1B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.8B | $1.4B | ||
| Q1 25 | $1.6B | $2.6B | ||
| Q4 24 | $1.7B | $2.0B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.4B | ||
| Q1 24 | $1.6B | $2.4B |
| Q4 25 | $-143.2M | $297.0M | ||
| Q3 25 | $43.7M | $-13.0M | ||
| Q2 25 | $-2.8M | $-163.0M | ||
| Q1 25 | $1.2M | $479.0M | ||
| Q4 24 | $10.1M | $375.0M | ||
| Q3 24 | $-25.2M | $-273.0M | ||
| Q2 24 | $72.3M | $-48.0M | ||
| Q1 24 | $47.8M | $496.0M |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 9.4% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 14.5% | — | ||
| Q1 24 | 12.7% | — |
| Q4 25 | -9.4% | 22.0% | ||
| Q3 25 | 4.8% | 1.1% | ||
| Q2 25 | 2.0% | -6.8% | ||
| Q1 25 | 2.7% | 26.6% | ||
| Q4 24 | 2.8% | 24.5% | ||
| Q3 24 | 1.0% | -20.4% | ||
| Q2 24 | 8.3% | 5.0% | ||
| Q1 24 | 5.9% | 29.7% |
| Q4 25 | -8.6% | 14.4% | ||
| Q3 25 | 2.6% | -1.1% | ||
| Q2 25 | -0.2% | -12.0% | ||
| Q1 25 | 0.1% | 18.2% | ||
| Q4 24 | 0.6% | 18.9% | ||
| Q3 24 | -1.6% | -22.6% | ||
| Q2 24 | 4.4% | -3.6% | ||
| Q1 24 | 2.9% | 20.6% |
| Q4 25 | $-1.25 | $1.34 | ||
| Q3 25 | $0.37 | $-0.08 | ||
| Q2 25 | $-0.01 | $-0.76 | ||
| Q1 25 | $0.01 | $2.19 | ||
| Q4 24 | $0.10 | $1.74 | ||
| Q3 24 | $-0.21 | $-1.26 | ||
| Q2 24 | $0.62 | $-0.23 | ||
| Q1 24 | $0.40 | $2.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $251.0M |
| Total DebtLower is stronger | $2.8B | $6.0B |
| Stockholders' EquityBook value | $1.8B | $5.0B |
| Total Assets | $7.3B | $15.8B |
| Debt / EquityLower = less leverage | 1.55× | 1.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $251.0M | ||
| Q3 25 | — | $335.0M | ||
| Q2 25 | — | $350.0M | ||
| Q1 25 | — | $426.0M | ||
| Q4 24 | $175.6M | $240.0M | ||
| Q3 24 | — | $213.0M | ||
| Q2 24 | — | $183.0M | ||
| Q1 24 | — | $263.0M |
| Q4 25 | $2.8B | $6.0B | ||
| Q3 25 | $3.0B | $6.5B | ||
| Q2 25 | $3.0B | $5.7B | ||
| Q1 25 | $3.0B | $6.6B | ||
| Q4 24 | $2.7B | $6.6B | ||
| Q3 24 | $2.8B | $6.4B | ||
| Q2 24 | $2.8B | $6.3B | ||
| Q1 24 | $2.7B | $6.7B |
| Q4 25 | $1.8B | $5.0B | ||
| Q3 25 | $2.0B | $4.8B | ||
| Q2 25 | $2.0B | $4.9B | ||
| Q1 25 | $2.0B | $5.0B | ||
| Q4 24 | $2.0B | $4.6B | ||
| Q3 24 | $2.1B | $4.3B | ||
| Q2 24 | $2.1B | $4.7B | ||
| Q1 24 | $2.2B | $4.8B |
| Q4 25 | $7.3B | $15.8B | ||
| Q3 25 | $7.6B | $15.5B | ||
| Q2 25 | $7.7B | $15.4B | ||
| Q1 25 | $7.7B | $15.7B | ||
| Q4 24 | $7.6B | $15.4B | ||
| Q3 24 | $7.5B | $15.1B | ||
| Q2 24 | $7.7B | $15.1B | ||
| Q1 24 | $7.6B | $15.6B |
| Q4 25 | 1.55× | 1.19× | ||
| Q3 25 | 1.52× | 1.37× | ||
| Q2 25 | 1.52× | 1.17× | ||
| Q1 25 | 1.50× | 1.32× | ||
| Q4 24 | 1.34× | 1.44× | ||
| Q3 24 | 1.34× | 1.48× | ||
| Q2 24 | 1.31× | 1.34× | ||
| Q1 24 | 1.24× | 1.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $321.2M | $66.0M |
| Free Cash FlowOCF − Capex | — | $-155.0M |
| FCF MarginFCF / Revenue | — | -7.5% |
| Capex IntensityCapex / Revenue | — | 10.7% |
| Cash ConversionOCF / Net Profit | — | 0.22× |
| TTM Free Cash FlowTrailing 4 quarters | — | $282.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $321.2M | $66.0M | ||
| Q3 25 | $26.7M | $90.0M | ||
| Q2 25 | $212.3M | $289.0M | ||
| Q1 25 | $-86.0M | $684.0M | ||
| Q4 24 | $141.7M | $164.0M | ||
| Q3 24 | $189.9M | $151.0M | ||
| Q2 24 | $90.6M | $390.0M | ||
| Q1 24 | $81.0M | $522.0M |
| Q4 25 | — | $-155.0M | ||
| Q3 25 | $-44.4M | $-168.0M | ||
| Q2 25 | — | $67.0M | ||
| Q1 25 | $-147.4M | $538.0M | ||
| Q4 24 | $90.7M | $-47.0M | ||
| Q3 24 | $146.6M | $-115.0M | ||
| Q2 24 | $34.1M | $185.0M | ||
| Q1 24 | $36.7M | $353.0M |
| Q4 25 | — | -7.5% | ||
| Q3 25 | -2.6% | -14.4% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | -9.0% | 20.4% | ||
| Q4 24 | 5.4% | -2.4% | ||
| Q3 24 | 9.2% | -9.5% | ||
| Q2 24 | 2.1% | 13.7% | ||
| Q1 24 | 2.2% | 14.6% |
| Q4 25 | — | 10.7% | ||
| Q3 25 | 4.2% | 22.1% | ||
| Q2 25 | — | 16.3% | ||
| Q1 25 | 3.7% | 5.5% | ||
| Q4 24 | 3.1% | 10.6% | ||
| Q3 24 | 2.7% | 22.0% | ||
| Q2 24 | 3.4% | 15.2% | ||
| Q1 24 | 2.7% | 7.0% |
| Q4 25 | — | 0.22× | ||
| Q3 25 | 0.61× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -71.67× | 1.43× | ||
| Q4 24 | 14.03× | 0.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 1.69× | 1.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLN
| Chlorinechlorinederivativesandothercoproducts | $456.2M | 27% |
| Causticsoda | $400.2M | 24% |
| Militaryandlawenforcement | $304.6M | 18% |
| Epoxyresins | $194.9M | 12% |
| Aromaticsandallylics | $164.4M | 10% |
| Commercial | $144.8M | 9% |
UGI
Segment breakdown not available.
